|Reference||Size||Price||Quantity||Add to cart|
The minimum purchase order quantity for the product is 1
ImmunoBead Assay for BCR/ABL human fusion protein detection. BCR–ABL fusion proteins show increased signaling through their ABL tyrosine kinase domain, which can be blocked by specific inhibitors, thereby providing effective treatment. This makes detection of BCR–ABL aberrations of utmost importance for diagnosis, classification and treatment of leukemia patients.
Tech Data Sheet